Adial Pharmaceuticals- Warrants (31/07/2023) Long Term Debt

As of the most recent data (June 2026), ADILW shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADILW's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Adial Pharmaceuticals- Warrants (31/07/2023) is outperforming or lagging.

Tracking ADILW's long-term debt over time shows whether Adial Pharmaceuticals- Warrants (31/07/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Adial Pharmaceuticals- Warrants (31/07/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

Adial Pharmaceuticals- Warrants (31/07/2023)'s long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.